Topical Cyclosporine and Disease Progression

Innovative Medical

Status and phase: Completed; Phase 4

Conditions: Staining; Disease Progression; Disease Severity; Schirmers; OSDI

Treatments: Drug: Endura; Drug: Restasis

Study type: Interventional

Funder types: Industry

Identifiers

NCT00567983

13717A

Details and patient eligibility

About

The purpose of this study is to evaluate the effect Restasis has in regards to disease progression.

Enrollment: 80 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Mild to Moderate dry eye symptoms

Exclusion criteria

• Current use of Restasis

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

80 participants in 2 patient groups, including a placebo group

1.

Active Comparator group

Treatment:

Drug: Restasis

2.

Placebo Comparator group

Treatment:

Drug: Endura